Metaxalone
Product Images NDC 10544-144

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metaxalone (NDC 10544-144). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

800mg 20ct (Label Metaxalone Tabs 800mg Bpi(10544 144 20) Amneal(65162 553 10) Rev1)

Metaxalone Tablets, 800 mg, in a package containing 20 tablets. The label includes storage instructions and notes that the product is prescription only. The labeler is Blenheim Pharmacal, Inc., with NDC 10544-144-20 indicated visibly on the label.*

FDA Label Image

Structure (Metaxalone Tablets 1)

Chemical structure of Metaxalone depicting its molecular composition including a substituted benzene ring and an oxazolidinone group.*

FDA Label Image

Figure 1 (Metaxalone Tablets 2)

A line graph depicting mean concentrations (ng/mL) of Metaxalone over time (hours) following an 800 mg dose under fasted (open circles) and fed (filled circles) conditions. The fed condition shows higher concentrations with a peak around 3–4 hours, while the fasted condition peaks earlier and at lower concentrations. Error bars indicate standard deviations.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.